Amsino International

Amsino International has acquired the assets of MedXL, including manufacturing facilities in Montreal, Canada, adding two FDA- and Health Canada-registered facilities and a distribution center. The acquisition doubles Amsino's syringe production capacity to over 500 million units annually.